FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Linda Vahdat

Research Profile

Disorders

Procedures

Chemicals & Drugs

Concepts & Ideas

Treatment Outcome

Co-author Network

Publications

TOP 3
Josef Martz; Juan Miguel Mosquera; Cristina R Antonescu; Sarika Jain; Lihui Qin; Linda Vahdat; Elizabeta C Popa
High-grade KIT-negative sarcoma of the small bowel in a patient with chronic myeloid leukemia receiving long-term tyrosine kinase inhibitors.
Linda Vahdat; Louise Yelle; Henri H Roché; Joseph A Sparano; Eva S Thomas; Craig A Bunnell; Monica Fornier; Gabriel N Hortobagyi; Miguel Martín; Pralay Mukhopadhyay; Ronald A Peck; Edith A Perez
Ixabepilone-associated peripheral neuropathy: data from across the phase II and III clinical trials.
Ellen Chuang; Arielle Flam; Melissa Forst; Katherine McCarville; Christos Paul; Sandra Shin; Rache Simmons; Alexander Swistel; Linda Vahdat; Michael Osborne
Breast cancer subtypes in Asian-Americans differ according to Asian ethnic group.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Linda Vahdat (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Josef Martz; Juan Miguel Mosquera; Cristina R Antonescu; Sarika Jain; Lihui Qin; Linda Vahdat; Elizabeta C Popa
High-grade KIT-negative sarcoma of the small bowel in a patient with chronic myeloid leukemia receiving long-term tyrosine kinase inhibitors.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2013;31(11):e181-5.
2012: Linda Vahdat; Louise Yelle; Henri H Roché; Joseph A Sparano; Eva S Thomas; Craig A Bunnell; Monica Fornier; Gabriel N Hortobagyi; Miguel Martín; Pralay Mukhopadhyay; Ronald A Peck; Edith A Perez
Ixabepilone-associated peripheral neuropathy: data from across the phase II and III clinical trials.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 2012;20(11):2661-8.
2012: Ellen Chuang; Arielle Flam; Melissa Forst; Katherine McCarville; Christos Paul; Sandra Shin; Rache Simmons; Alexander Swistel; Linda Vahdat; Michael Osborne
Breast cancer subtypes in Asian-Americans differ according to Asian ethnic group.
Journal of immigrant and minority health / Center for Minority Public Health 2012;14(5):754-8.
2012: Vicente Valero; Eduard Vrdoljak; Binghe Xu; Eva Thomas; Linda Vahdat; Linda Bosserman; Henry Gómez; Rubi Khaw Li; Alexey Manikhas; Carlos Medina; Pralay Mukhopadhyay; Diane Opatt; Jungsil Ro; Joseph A Sparano
Maintenance of clinical efficacy after dose reduction of ixabepilone plus capecitabine in patients with anthracycline- and taxane-resistant metastatic breast cancer: a retrospective analysis of pooled data from 2 phase III randomized clinical trials.
Clinical breast cancer 2012;12(4):240-6.
2012: Sarika Jain; Christina Lam; Maureen E Lane; Vivek Mittal; Anne Moore; Jennifer O'Loughlin; Shahin Rafii; Sarah Schneider; Alexander Swistel; Rebecca N Baergen; Marissa Boeck; Paul Christos; Ellen Chuang; Tessa Cigler; Marta V Cobham; Diana Donovan; Maureen M Ward; Naomi Wiener; Linda Vahdat
Incremental increase in VEGFR1⁺ hematopoietic progenitor cells and VEGFR2⁺ endothelial progenitor cells predicts relapse and lack of tumor response in breast cancer patients.
Breast cancer research and treatment 2012;132(1):235-42.
2012: Jacek Jassem; Mark Karwal; Ronald Peck; Valerie Poulart; Mario Campone; Luis Fein; Linda Vahdat
Ixabepilone plus capecitabine in advanced breast cancer patients with early relapse after adjuvant anthracyclines and taxanes: a pooled subset analysis of two phase III studies.
Breast (Edinburgh, Scotland) 2012;21(1):89-94.
2011: Sarika Jain; Linda Vahdat
Eribulin mesylate.
Clinical cancer research : an official journal of the American Association for Cancer Research 2011;17(21):6615-22.
2011: Henri Roché; Linda Vahdat
Treatment of metastatic breast cancer: second line and beyond.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2011;22(5):1000-10.
2011: Fang Fang; Sevin Turcan; Andreas Rimner; Andrew Kaufman; Dilip Giri; Luc G T Morris; Ronglai Shen; Venkatraman Seshan; Qianxing Mo; Adriana Heguy; Stephen B Baylin; NITA AHUJA; Agnes Viale; Joan Massague; Larry Norton; Linda Vahdat; Mary Ellen Moynahan; Timothy Chan
Breast cancer methylomes establish an epigenomic foundation for metastasis.
Science translational medicine 2011;3(75):75ra25.
2010: Phuong K Morrow; Stephen Divers; Louise Provencher; Shiuh-Wen Luoh; Teresa M Petrella; Marius Giurescu; Thomas Schmelter; Yao Wang; Gabriel N Hortobagyi; Linda Vahdat
Phase II study evaluating the efficacy and safety of sagopilone (ZK-EPO) in patients with metastatic breast cancer that has progressed following chemotherapy.
Breast cancer research and treatment 2010;123(3):837-42.
2010: Gabriel N Hortobagyi; Henry L Gomez; Rubi K Li; Hyun-Cheol Chung; Luis E Fein; Valorie F Chan; Jacek Jassem; Guillermo L Lerzo; Xavier B Pivot; Fernando Hurtado de Mendoza; Binghe Xu; Linda Vahdat; Ronald A Peck; Pralay Mukhopadhyay; Henri Roché
Analysis of overall survival from a phase III study of ixabepilone plus capecitabine versus capecitabine in patients with MBC resistant to anthracyclines and taxanes.
Breast cancer research and treatment 2010;122(2):409-18.
2009: Nicholas J Petrelli; Eric P Winer; Julie R Brahmer; Sarita Dubey; Sonali Smith; Charles Thomas; Linda Vahdat; Jennifer Obel; Nicholas Vogelzang; Maurie Markman; John W Sweetenham; David G Pfister; Mark G Kris; Lynn Schuchter; Raymond Sawaya; Derek Raghavan; Patricia Anne Ganz; Barnett Kramer
Clinical Cancer Advances 2009: major research advances in cancer treatment, prevention, and screening--a report from the American Society of Clinical Oncology.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(35):6052-69.
2009: Dingcheng Gao; Daniel Nolan; Kevin McDonnell; Linda Vahdat; Robert Benezra; Nasser Altorki; Vivek Mittal
Bone marrow-derived endothelial progenitor cells contribute to the angiogenic switch in tumor growth and metastatic progression.
Biochimica et biophysica acta 2009;1796(1):33-40.
2009: Linda Vahdat; Brian Pruitt; Carol J Fabian; Ragene R Rivera; David A Smith; Elizabeth Tan-Chiu; Jonathan Wright; Antoinette R Tan; Noshir A Dacosta; Ellen Chuang; John Smith; Joyce O'Shaughnessy; Dale E Shuster; Nicole L Meneses; Kumari Chandrawansa; Fang Fang; Patricia E Cole; Simon Ashworth; Joanne L Blum
Phase II study of eribulin mesylate, a halichondrin B analog, in patients with metastatic breast cancer previously treated with an anthracycline and a taxane.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(18):2954-61.
2009: Tianhong Li; P J Christos; Joseph A Sparano; Dawn Hershman; S Hoschander; K O'Brien; J J Wright; Linda Vahdat
Phase II trial of the farnesyltransferase inhibitor tipifarnib plus fulvestrant in hormone receptor-positive metastatic breast cancer: New York Cancer Consortium Trial P6205.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2009;20(4):642-7.
2008: Linda Vahdat
Choosing a taxane for adjuvant treatment of breast cancer: more than a flip of the coin?
Nature clinical practice. Oncology 2008;5(10):570-1.
2008: Craig A Bunnell; Linda Vahdat; Lee Schwartzberg; Julie R Gralow; Judith Klimovsky; Valerie Poulart; Ronald Peck; Eva Thomas
Phase I/II study of ixabepilone plus capecitabine in anthracycline-pretreated/resistant and taxane-resistant metastatic breast cancer.
Clinical breast cancer 2008;8(3):234-41.
2008: Linda Vahdat
Ixabepilone: a novel antineoplastic agent with low susceptibility to multiple tumor resistance mechanisms.
The oncologist 2008;13(3):214-21.
2008: Julie R Gralow; Robert F Ozols; Dean F Bajorin; Bruce D Cheson; Howard M Sandler; Eric P Winer; James Bonner; George D Demetri; Walter Curran; Patricia Anne Ganz; Barnett S Kramer; Mark G Kris; Maurie Markman; Robert J Mayer; Derek Raghavan; Scott Ramsey; Gregory H Reaman; Raymond Sawaya; Lynn Schuchter; John W Sweetenham; Linda Vahdat; Nancy E Davidson; Richard L Schilsky; Allen S Lichter
Clinical cancer advances 2007: major research advances in cancer treatment, prevention, and screening--a report from the American Society of Clinical Oncology.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(2):313-25.
2008: Rakhi P Naik; David Jin; Ellen Chuang; Ellen G Gold; Eleni Tousimis; Anne L Moore; Paul J Christos; Tatiana de Dalmas; Diana Donovan; Shahin Rafii; Linda Vahdat
Circulating endothelial progenitor cells correlate to stage in patients with invasive breast cancer.
Breast cancer research and treatment 2008;107(1):133-8.
2007: Komal Jhaveri; Peter Halperin; Sandra J Shin; Linda Vahdat
Erythema nodosum secondary to aromatase inhibitor use in breast cancer patients: case reports and review of the literature.
Breast cancer research and treatment 2007;106(3):315-8.
2007: Eva S Thomas; Henry L Gomez; Rubi K Li; Hyun-Cheol Chung; Luis E Fein; Valorie F Chan; Jacek Jassem; Xavier B Pivot; Judith V Klimovsky; Fernando Hurtado de Mendoza; Binghe Xu; Mario Campone; Guillermo L Lerzo; Ronald A Peck; Pralay Mukhopadhyay; Linda Vahdat; Henri Roché
Ixabepilone plus capecitabine for metastatic breast cancer progressing after anthracycline and taxane treatment.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(33):5210-7.
2007: Clare Taylor; Dawn Hershman; Nina Shah; Nicole Suciu-Foca; Daniel P Petrylak; Robert N Taub; Linda Vahdat; Bin Cheng; Mark D Pegram; Keith L Knutson; Raphael Clynes
Augmented HER-2 specific immunity during treatment with trastuzumab and chemotherapy.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(17):5133-43.
2007: Eva Thomas; Josep Tabernero; Monica Fornier; Pierfranco Conté; Pierre Fumoleau; Ana Lluch; Linda Vahdat; Craig A Bunnell; Howard A Burris; Patrice Viens; José Baselga; Edgardo Rivera; Valentina Guarneri; Valerie Poulart; Judith Klimovsky; David Lebwohl; Miguel Martin
Phase II clinical trial of ixabepilone (BMS-247550), an epothilone B analog, in patients with taxane-resistant metastatic breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(23):3399-406.
2007: Edith A Perez; Guillermo Lerzo; Xavier Pivot; Eva Thomas; Linda Vahdat; Linda Bosserman; Patrice Viens; Can Cai; Brian Mullaney; Ronald Peck; Gabriel N Hortobagyi
Efficacy and safety of ixabepilone (BMS-247550) in a phase II study of patients with advanced breast cancer resistant to an anthracycline, a taxane, and capecitabine.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(23):3407-14.
2007: Henri Roché; Louise Yelle; Francesco Cognetti; Louis Mauriac; Craig A Bunnell; Joseph A Sparano; Pierre Kerbrat; Jean-Pierre Delord; Linda Vahdat; Ronald Peck; David Lebwohl; Rana Ezzeddine; Hervé Curé
Phase II clinical trial of ixabepilone (BMS-247550), an epothilone B analog, as first-line therapy in patients with metastatic breast cancer previously treated with anthracycline chemotherapy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(23):3415-20.
2007: Linda Vahdat; D J Cohen; D Zipin; K S Lo; Daniel Donovan; David Savage; Amy D Tiersten; Gwen Nichols; Andrea B Troxel; Charles Hesdorffer
Randomized trial of low-dose interleukin-2 vs cyclosporine A and interferon-gamma after high-dose chemotherapy with peripheral blood progenitor support in women with high-risk primary breast cancer.
Bone marrow transplantation 2007;40(3):267-72.
2007: Tara L Huston; Peter I Pressman; Anne Moore; Linda Vahdat; Syed A Hoda; Meredith Kato; Douglas Weinstein; Eleni Tousimis
The presentation of contralateral axillary lymph node metastases from breast carcinoma: a clinical management dilemma.
The breast journal 2007;13(2):158-64.
2007: Robert F Ozols; Roy S Herbst; Yolonda L Colson; Julie R Gralow; James Bonner; Walter Curran; Burton L Eisenberg; Patricia Anne Ganz; Barnett S Kramer; Mark G Kris; Maurie Markman; Robert J Mayer; Derek Raghavan; Gregory H Reaman; Raymond Sawaya; Richard L Schilsky; Lynn Schuchter; John W Sweetenham; Linda Vahdat; Rodger J Winn
Clinical cancer advances 2006: major research advances in cancer treatment, prevention, and screening--a report from the American Society of Clinical Oncology.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(1):146-62.
2006: Kutluk Oktay; Ozgur Oktem; Andrea Reh; Linda Vahdat
Measuring the impact of chemotherapy on fertility in women with breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(24):4044-6.
2006: Joseph A Sparano; Stacy Moulder; Aslamuzzaman Kazi; Linda Vahdat; Tianhong Li; Christine Pellegrino; Pamela N Munster; Mokenge Malafa; David Lee; Shira Hoschander; Una Hopkins; Dawn Hershman; John J Wright; Said M Sebti
Targeted inhibition of farnesyltransferase in locally advanced breast cancer: a phase I and II trial of tipifarnib plus dose-dense doxorubicin and cyclophosphamide.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(19):3013-8.
2006: Alison K Conlin; Linda Vahdat
Dermatological toxicity of ixabepilone.
Anticancer research 2006;26(3B):2279-80.
2006: Amy D Tiersten; M Selleck; Daniel H Smith; I Wertheim; Eliaz Kaufman; Dawn Hershman; Linda Vahdat; David G Savage; R B MacArthur; Charles Hesdorffer
Phase I/II study of tandem cycles of high-dose chemotherapy followed by autologous hematopoietic stem cell support in women with advanced ovarian cancer.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2006;16(1):57-64.
2006: Roy S Herbst; Dean F Bajorin; Harry Bleiberg; Diane Blum; Desirée Hao; Bruce E Johnson; Robert F Ozols; George D Demetri; Patricia Anne Ganz; Mark G Kris; Bernard Levin; Maurie Markman; Derek Raghavan; Gregory H Reaman; Raymond Sawaya; Lynn Schuchter; John W Sweetenham; Linda Vahdat; Everett E Vokes; Rodger J Winn; Robert J Mayer
Clinical Cancer Advances 2005: major research advances in cancer treatment, prevention, and screening--a report from the American Society of Clinical Oncology.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(1):190-205.
2005: Michael D Stubblefield; Linda Vahdat; Casilda Balmaceda; Andrea B Troxel; Charles Hesdorffer; C L Gooch
Glutamine as a neuroprotective agent in high-dose paclitaxel-induced peripheral neuropathy: a clinical and electrophysiologic study.
Clinical oncology (Royal College of Radiologists (Great Britain)) 2005;17(4):271-6.
2005: Donna L Skerrett; Ellery M Moore; David S Bernstein; Linda Vahdat
Cytokine genotype polymorphisms in breast carcinoma: associations of TGF-beta1 with relapse.
Cancer investigation 2005;23(3):208-14.
2004: Allyson J Ocean; Linda Vahdat
Chemotherapy-induced peripheral neuropathy: pathogenesis and emerging therapies.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 2004;12(9):619-25.
2004: Amy S Clark; Linda Vahdat
Chemotherapy-induced palmar-plantar erythrodysesthesia syndrome: etiology and emerging therapies.
Supportive cancer therapy 2004;1(4):213-8.
2003: Diane M F Savarese; Gayle Savy; Linda Vahdat; Paul E Wischmeyer; Barbara Corey
Prevention of chemotherapy and radiation toxicity with glutamine.
Cancer treatment reviews 2003;29(6):501-13.
2003: Amy D Tiersten; Caron Nelsen; Susan Talbot; Linda Vahdat; Robert Fine; Andrea B Troxel; Lois Brafman; Laureen Shriberg; Karen Antman; Daniel P Petrylak
A phase II trial of docetaxel and estramustine in patients with refractory metastatic breast carcinoma.
Cancer 2003;97(3):537-44.
2002: Gwen Nichols; K de Castro; L-X Wei; M Griffin; N Lin; A Oratzi; Vundavalli Murty; Andrea B Troxel; Linda Vahdat; Charles Hesdorffer
Therapy-related myelodysplastic syndrome after autologous stem cell transplantation for breast cancer.
Leukemia 2002;16(9):1673-9.
2002: Linda Vahdat; Casilda Balmaceda; Kyriakos P Papadopoulos; Dana M Frederick; Daniel Donovan; E Sharpe; Eliaz Kaufman; David Savage; Amy D Tiersten; Gwen Nichols; J Haythe; Andrea B Troxel; Karen Antman; Charles Hesdorffer
Phase II trial of sequential high-dose chemotherapy with paclitaxel, melphalan and cyclophosphamide, thiotepa and carboplatin with peripheral blood progenitor support in women with responding metastatic breast cancer.
Bone marrow transplantation 2002;30(3):149-55.
2001: Judith S Jacobson; Andrea B Troxel; J Evans; L Klaus; Linda Vahdat; D Kinne; K M Lo; A Moore; P J Rosenman; E L Kaufman; Alfred I Neugut; Victor R Grann
Randomized trial of black cohosh for the treatment of hot flashes among women with a history of breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(10):2739-45.
2001: Linda Vahdat; Kyriakos P Papadopoulos; D Lange; S Leuin; Eliaz Kaufman; Daniel Donovan; Dana M Frederick; E Bagiella; Amy D Tiersten; Gwen Nichols; Thomas J Garrett; David Savage; Karen Antman; Charles Hesdorffer; Casilda Balmaceda
Reduction of paclitaxel-induced peripheral neuropathy with glutamine.
Clinical cancer research : an official journal of the American Association for Cancer Research 2001;7(5):1192-7.
2001: Kyriakos P Papadopoulos; Merrill J Egorin; M Huang; Andrea B Troxel; Eliaz Kaufman; Casilda Balmaceda; Linda Vahdat; Charles Hesdorffer
The pharmacokinetics and pharmacodynamics of high-dose paclitaxel monotherapy (825 mg/m2 continuous infusion over 24 h) with hematopoietic support in women with metastatic breast cancer.
Cancer chemotherapy and pharmacology 2001;47(1):45-50.
1999: R T Lee; Martin W Oster; Casilda Balmaceda; Charles Hesdorffer; Linda Vahdat; Kyriakos P Papadopoulos
Bilateral facial nerve palsy secondary to the administration of high-dose paclitaxel.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1999;10(10):1245-7.
1999: Kyriakos P Papadopoulos; Casilda Balmaceda; Michael R Fetell; Eliaz Kaufman; Linda Vahdat; J Bruce; Michael B Sisti; SR Isaacson; R De LaPaz; David G Savage; Andrea B Troxel; Karen Antman; Charles Hesdorffer
A phase I study of high-dose BCNU, etoposide and escalating-dose thiotepa (BTE) with hematopoietic progenitor cell support in adults with recurrent and high-risk brain tumors.
Journal of neuro-oncology 1999;44(2):155-62.
1999: Kyriakos P Papadopoulos; Janet Ayello; RF Reiss; Andrea B Troxel; Eliaz Kaufman; Linda Vahdat; Karen Antman; Charles Hesdorffer
CD34+ cell dose requirements for rapid engraftment in a sequential high-dose chemotherapy regimen of paclitaxel, melphalan, and cyclophosphamide, thiotepa, and carboplatin (CTCb) with PBPC support in metastatic breast cancer.
Journal of hematotherapy & stem cell research 1999;8(4):357-63.
1998: Kyriakos P Papadopoulos; JH Garvin; Michael R Fetell; Linda Vahdat; Thomas J Garrett; David G Savage; Casilda Balmaceda; J Bruce; Michael B Sisti; SR Isaacson; R De LaPaz; Ria Hawks; E Bagiella; Karen Antman; Charles Hesdorffer
High-dose thiotepa and etoposide-based regimens with autologous hematopoietic support for high-risk or recurrent CNS tumors in children and adults.
Bone marrow transplantation 1998;22(7):661-7.
1998: Linda Vahdat; Kyriakos P Papadopoulos; Casilda Balmaceda; T McGovern; J Dunleavy; Eliaz Kaufman; B Fung; Thomas J Garrett; David Savage; Amy D Tiersten; Janet Ayello; E Bagiella; Daniel F Heitjan; Karen Antman; Charles Hesdorffer
Phase I trial of sequential high-dose chemotherapy with escalating dose paclitaxel, melphalan, and cyclophosphamide, thiotepa, and carboplatin with peripheral blood progenitor support in women with responding metastatic breast cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 1998;4(7):1689-95.
1998: Charles Hesdorffer; Janet Ayello; Maureen Ward; Andreas Kaubisch; Linda Vahdat; Casilda Balmaceda; Thomas J Garrett; Michael R Fetell; RF Reiss; Arthur Bank; Karen Antman
Phase I trial of retroviral-mediated transfer of the human MDR1 gene as marrow chemoprotection in patients undergoing high-dose chemotherapy and autologous stem-cell transplantation.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(1):165-72.
1997: Linda Vahdat; K Antman
High-dose chemotherapy with autologous stem cell support for breast cancer.
Current opinion in hematology 1997;4(6):381-9.
1997: Kyriakos P Papadopoulos; Janet Ayello; S Tugulea; Daniel F Heitjan; C Williams; RF Reiss; Linda Vahdat; Nicole Suciu-Foca; Karen Antman; Charles Hesdorffer
Harvest quality and factors affecting collection and engraftment of CD34+ cells in patients with breast cancer scheduled for high-dose chemotherapy and peripheral blood progenitor cell support.
Journal of hematotherapy 1997;6(1):61-8.
1997: Thomas J Garrett; Linda Vahdat; D W Kinne
Systemic adjuvant therapy of breast cancer.
Journal of surgical oncology 1997;64(2):167-72.
1996: A A Ross; T J Layton; A B Ostrander; J L Passos-Coelho; JANICE DAVIS SPROUL; A M Huelskamp; Stephen J Noga; Nancy E Davidson; M J Kennedy; Brenda W Cooper; Stanton L Gerson; Hillard M Lazarus; K Holland; Stefan Gluck; T J Moss; A Kaubish; Linda Vahdat; K Antman
Comparative analysis of breast cancer contamination in mobilized and nonmobilized hematopoietic grafts.
Journal of hematotherapy 1996;5(5):549-52.
1995: Linda Vahdat; G Raptis; DW Fennelly; N Hamilton; Lilian Reich; A Tiersten; M Harrison; Clifford Hudis; Malcolm A S Moore; Tzy-Jyun Yao
Rapidly cycled courses of high-dose alkylating agents supported by filgrastim and peripheral blood progenitor cells in patients with metastatic breast cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 1995;1(11):1267-73.
1995: Linda Vahdat; Karen Antman
High-dose therapy for breast cancer.
Blood reviews 1995;9(3):191-200.
1995: J Crown; N Hamilton; G Raptis; A Kritz; Linda Vahdat; Larry Norton
Carboplatin and etoposide in metastatic breast cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1995;6(4):403.
1995: John Crown; G Raptis; N Hamilton; DW Fennelly; Linda Vahdat; Larry Norton
High-dose chemotherapy of breast cancer: current status and developmental strategies.
European journal of cancer (Oxford, England : 1990) 1995;31A(5):809-11.
1995: Linda Vahdat; G Raptis; DW Fennelly; John Crown
High-dose chemotherapy of metastatic breast cancer: a review.
Cancer investigation 1995;13(5):505-10.
1994: Linda Vahdat; Peter Maslak; W H Miller; A Eardley; Glenn Heller; David A Scheinberg; RP Warrell
Early mortality and the retinoic acid syndrome in acute promyelocytic leukemia: impact of leukocytosis, low-dose chemotherapy, PMN/RAR-alpha isoform, and CD13 expression in patients treated with all-trans retinoic acid.
Blood 1994;84(11):3843-9.
1994: Linda Vahdat; E T Wong; M J Wile; Marc K Rosenblum; Kathleen M Foley; RP Warrell
Therapeutic and neurotoxic effects of 2-chlorodeoxyadenosine in adults with acute myeloid leukemia.
Blood 1994;84(10):3429-34.
1994: DW Fennelly; Linda Vahdat; J Schneider; Lilian Reich; N Hamilton; T Hakes; G Raptis; C Wasserheit; A Kritz; S Gulati
High-intensity chemotherapy with peripheral blood progenitor cell support.
Seminars in oncology 1994;21(2 Suppl 2):21-5; quiz 26, 58.
1993: John Crown; Linda Vahdat; DW Fennelly; P Francis; C Wasserheit; Clifford Hudis; A Kritz; J Schneider; N Hamilton; Teresa A Gilewski
High-intensity chemotherapy with hematopoietic support in breast cancer.
Annals of the New York Academy of Sciences 1993;698():378-88.
1993: John Crown; A Kritz; Linda Vahdat; Lilian Reich; Malcolm A S Moore; N Hamilton; J Schneider; M Harrison; Teresa A Gilewski; Clifford Hudis
Rapid administration of multiple cycles of high-dose myelosuppressive chemotherapy in patients with metastatic breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1993;11(6):1144-9.